Development of new antibacterial agents

  • Assia Keniche Laboratoire de Chimie Organique, Substances Naturelles et Analyses (COSNA), University of Tlemcen, Algeria
  • Samia Bellifa Laboratory: Antifungal Antibiotic, Physico-Chemical Synthesis and Biological Activity, University of Tlemcen, University center of Naâma, Algeria
  • Hafida Hassaine Laboratoire de microbiologie appliquée à l’agroalimentaire au biomédical et a l’environnement (LAMAABE), University of Tlemen, Algeria
  • Joseph Kajima Mulengi Laboratoire de Chimie Organique, Substances Naturelles et Analyses (COSNA), University of Tlemcen, Algeria
Keywords: Aziridines, Phtaloyl acide, Strained heterocycles, Antibiotics

Abstract

Background: Antibiotics, as miraculous drugs, have been used extensively to confront fatal infection, even without prescriptions. However, the inappropriate and disproportionate use of antibiotics have led to the emergence of new drug-resistant bacteria1, which causes a high risk of serious diseases and dramatically aggravates the clinical complications in hospitals.

Methods: By using the peptide coupling protocol, a simple straightforward synthesis of functionalized aziridines has been developed. By means of this synthetic strategy from readily available N-phtaloyl acide and 2-methylbenzosulfonate aziridine using DCC as coupling agent, new tosylates aziridines could be obtained. The coupling reactions occurred without a ring opening of the three membered ring.

Results: This work describes new results of our ongoing research targeting new derivatives of biological interests. All the compounds were screened for their antibacterial activity; they all showed comparable moderate to good growth inhibitory activity with reference to tetracyclin and gentamicin.

Conclusion: In conclusion, we reported the synthesis and a preliminary antibacterial evaluation of novel functionalized tosylaziridines. The synthetic strategy relies on the coupling reactions between tosylaziridines and amino acids. Moreover, and besides showing interesting antibacterial activities, the series of novel compounds can be further improved to serve as potential drug against nosocomial diseases.

Downloads

Download data is not yet available.
Published
2017-06-08
Section
Conference proceedings and abstracts